Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-25-012238
Filing Date
2025-01-24
Accepted
2025-01-24 16:35:25
Documents
3

Document Format Files

Seq Description Document Type Size
1 S-3/A d873142ds3a.htm S-3/A 64154
2 EX-23.1 d873142dex231.htm EX-23.1 1807
3 EX-FILING FEES d873142dexfilingfees.htm EX-FILING FEES 105735
  Complete submission text file 0001193125-25-012238.txt   172941
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-280918 | Film No.: 25554633
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)